Business
Suda Pharmaceuticals share price soars 200% on TGA approval – Motley Fool Australia
The Suda Pharmaceuticals share price is soaring over 200% following TGA approval for its insomnia treatment product, ZolpiMist.
The Suda Pharmaceuticals Ltd(ASX: SUD) share price has soared 207.4% today, at the time of writing. The surge came following the company’s announcement that its Zolpimist product has been approved by the TGA (Therapeutic Goods Administration). ZolpiMist is an oral spray for the treatment of insomnia.
In an investor presentation released by Suda Pharmaceuticals earlier this month, the company estimated the market for insomnia treatments will be approximately US$4 billion by 2026. Furthermore, a…
-
Noosa News10 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News22 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub
-
Noosa News23 hours agoSchools ban e-bikes | Noosa Today
-
Noosa News8 hours agoTeenage girl dies in hit-and-run, police hunt for ute